Epidemiology, Diagnosis, and Management of Polycystic Ovary Syndrome

    December 2013 in “ Clinical epidemiology ”
    Susan M. Sirmans, Kristen A. Pate
    Studysummary This article reviews the prevalence, risk factors, and clinical manifestations of polycystic ovary syndrome, highlighting current treatment and management options, but reports no new research findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on dovepress.com →
    Discuss this study in the Community →

    Research cited in this study 18

    1. Consensus on Women's Health Aspects of Polycystic Ovary Syndrome: The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group Fertility and sterility · 2011
    2. Non-Polycystic Ovary Syndrome–Related Endocrine Disorders Associated with Hirsutism European Journal of Clinical Investigation · 2011
    3. Ovarian Hypertension: Polycystic Ovary Syndrome Endocrinology and Metabolism Clinics of North America · 2011
    4. Treatment Options for Polycystic Ovary Syndrome International journal of women's health · 2011
    5. Polycystic Ovary Syndrome: Etiology, Pathogenesis, and Diagnosis Nature Reviews Endocrinology · 2011
    6. The Prevalence of Polycystic Ovary Syndrome in a Community Sample of Iranian Population: Iranian PCOS Prevalence Study Reproductive Biology and Endocrinology · 2011
    7. Polycystic Ovary Syndrome: A Complex Condition with Psychological, Reproductive, and Metabolic Manifestations That Impacts Health Across the Lifespan BMC Medicine · 2010
    8. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline The Journal of Clinical Endocrinology and Metabolism · 2006
    9. Diagnosis and Management of the Dermatologic Manifestations of Polycystic Ovary Syndrome Dermatologic therapy · 2006
    10. Endothelial Dysfunction in PCOS: Role of Obesity and Adipose Hormones The American Journal of Medicine · 2006
    11. The Prevalence of Androgen Excess Among Patients With Minimal Unwanted Hair Growth American Journal of Obstetrics and Gynecology · 2004
    12. Androgen Excess in Women: Experience with Over 1000 Consecutive Patients The Journal of Clinical Endocrinology and Metabolism · 2004
    13. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome Fertility and Sterility · 2004
    14. The Pathophysiology of Polycystic Ovary Syndrome Clinical endocrinology · 2003
    15. Cardiovascular Risk Factors in Young Czech Females with Polycystic Ovary Syndrome Human Reproduction · 2003
    16. A Prospective Study of the Prevalence of Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain The Journal of Clinical Endocrinology and Metabolism · 2000
    17. Prevalence of Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study The Journal of Clinical Endocrinology and Metabolism · 1998
    18. Polycystic Ovary Syndrome: Clinical and Biochemical Features New England journal of medicine/˜The œNew England journal of medicine · 1995

    Related research 4

    1. Current Aspects of Polycystic Ovary Syndrome: A Literature Review Revista Da Associacao Medica Brasileira · 2016
    2. Caring for Women with Polycystic Ovary Syndrome The Nurse Practitioner · 2016
    3. Polycystic Ovary Syndrome and Acne Skin therapy letter · 2011
    4. Screening for Diabetes in Women with Polycystic Ovary Syndrome Canadian Medical Association Journal · 2007